Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00726310 · ClinicalTrials.gov registry record

Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability

A clinical trial of Degenerative Disc Disease and Degenerative Spondylolisthesis, sponsored by Zimmer Biomet.

Completed
Registry status
202
Enrollment target
2
Study locations

NCT00726310: Completed study of Degenerative Disc Disease and Degenerative Spondylolisthesis, sponsored by Zimmer Biomet.

NCT00726310 is a study of Degenerative Disc Disease and Degenerative Spondylolisthesis that has completed, run by Zimmer Biomet. The registered enrollment target is 202 participants, above the 164-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (23% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00726310, a study of Degenerative Disc Disease and Degenerative Spondylolisthesis, has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
202 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this open, multi-center study is to prospectively collect outcome data on patients who are having lumbar spinal fusion surgery with implantation of the SpineLink® system.

Primary Outcome

AP radiographs will be evaluated for the evidence of bridging virgin trabecular bone across the fusion mass. In order for a patient to be considered fused, A/P radiographs must show evidence of bridging virgin trabecular bone across the fusion mass.

Interventions

  • DEVICE SpineLink® , SpineLink® II

Study Locations (2)

California

  • Alvarado Orthopedic Clinic - San Diego

Florida

  • Rogozinski Orthopedic Clinic - Jacksonville

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 2000-05
Est. Completion 2009-11
Zimmer Biomet

115 total trials

What the finished NCT00726310 record still lists

NCT00726310 is an observational study that tracks outcomes without assigning an intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, above the 164-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (23% higher).

The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which SpineLink® , SpineLink® II is the first listed.

NCT00726310 reports a single indexed study location in California, Florida.

Frequently Asked Questions

What is clinical trial NCT00726310 about?

NCT00726310 is a clinical study titled "Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability". The purpose of this open, multi-center study is to prospectively collect outcome data on patients who are having lumbar spinal fusion surgery with implantation of the SpineLink® system.

What is the current status of trial NCT00726310?

This trial is currently completed. The enrollment target is 202 participants. The study started on 2000-05. Estimated completion is 2009-11.

What conditions does trial NCT00726310 study?

This clinical trial studies the following conditions: Degenerative Disc Disease, Degenerative Spondylolisthesis.

What interventions are being tested in trial NCT00726310?

The interventions under investigation include: SpineLink® , SpineLink® II (DEVICE).

Who is sponsoring clinical trial NCT00726310?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00726310 being conducted?

This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00726310's enrollment target sits among peer trials

202 12th of 42 higher than 31 of 42 other Degenerative Disc Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05272254 · 202 participants · Phase 2

    Povidone Iodine Efficacy Study

  • NCT05701280 · 202 participants · NA

    Pilot/Pivotal Study of DBS+Rehab After Stroke

  • NCT05932589 · 202 participants

    Neurophysiologic Biomarkers in Rett Syndrome

  • NCT06014931 · 202 participants · NA

    Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00726310, the US trial registry maintained by the National Library of Medicine. NCT00726310 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.